These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1583135

  • 1. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
    Jones RN, Erwin ME.
    J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
    [Abstract] [Full Text] [Related]

  • 2. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN, Erwin ME.
    Diagn Microbiol Infect Dis; 1992 May; 15(8):693-701. PubMed ID: 1478050
    [Abstract] [Full Text] [Related]

  • 3. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
    Jones RN, Erwin ME, Gooding BB.
    J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW, Jones RN, Barry AL, Thornsberry C, Fuchs PC, Gavan TL, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [Abstract] [Full Text] [Related]

  • 6. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN, Gavan TL, Barry AL, Thornsberry C, Gibbs DL.
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [Abstract] [Full Text] [Related]

  • 7. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.
    Pfaller MA, Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):893-5. PubMed ID: 8494387
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
    Jones RN, Thornsberry C, Barry AL, Ayers L, Brown S, Daniel J, Fuchs PC, Gavan TL, Gerlach EH, Matsen JM.
    J Clin Microbiol; 1984 Sep; 20(3):409-12. PubMed ID: 6490826
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.
    Jones RN, Erwin ME, Barrett MS.
    Diagn Microbiol Infect Dis; 1992 Sep; 15(4):379-81. PubMed ID: 1319303
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G, Fallat V, Siebelist J, Durkin JW, Lipschitz ER, McGarry DH.
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807).
    Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1988 Apr; 32(4):443-9. PubMed ID: 3377457
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
    Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
    Fuchs PC, Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1990 May; 34(5):914-7. PubMed ID: 2193626
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disks.
    Jones RN, Thornsberry C, Barry AL.
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):87-92. PubMed ID: 3967476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.